Related Experiment Video

Updated: Apr 1, 2026

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration
10:14

Author Spotlight: Ex Vivo OCT-Based Multimodal Imaging of Human Donor Eyes for Research into Age-Related Macular Degeneration

Published on: May 26, 2023

4.4K

Aging and Vision

Marcel V Alavi1

  • 1Department of Ophthalmology, University of California, San Francisco, 10 Koret Way, 94143, San Francisco, CA, USA. marcel.alavi@gmail.com.

Advances in Experimental Medicine and Biology
|October 3, 2015
PubMed

Insights

Longevity pathways regulate lifespan and impact age-related diseases. Targeting these pathways may offer new treatments for blinding eye conditions like age-related macular degeneration by slowing photoreceptor aging.

Area of Science:

  • Gerontology and ophthalmology
  • Molecular biology and genetics

Background:

  • Aging is influenced by genetic, biochemical, and cellular pathways.
  • These longevity pathways are implicated in age-related diseases.
  • Major blinding diseases, including cataract, glaucoma, age-related macular degeneration (AMD), and diabetic retinopathy, involve longevity pathways in the eye.

Purpose of the Study:

  • To explore the role of longevity pathways in age-related eye diseases.
  • To investigate the potential of pharmaceutical targeting of longevity pathways for therapeutic interventions.
  • To propose that retinal degeneration can be viewed as accelerated aging of photoreceptors.

Main Methods:

  • Review of existing literature on aging pathways and eye diseases.
  • Analysis of the relevance of longevity pathways in ocular pathologies.
  • Conceptual framework development linking lifespan extension to photoreceptor health.

Main Results:

  • Longevity pathways are critical regulators of lifespan and are involved in age-related diseases.
  • These pathways play a significant role in the pathogenesis of major blinding eye conditions.
  • Pharmaceutical targeting of longevity pathways has shown promise in extending healthy lifespan in model systems.

Conclusions:

  • Targeting longevity pathways presents a potential therapeutic strategy for delaying or slowing age-related eye diseases.
  • Interventions aimed at extending healthy lifespan may also mitigate photoreceptor loss.
  • Viewing retinal degeneration as accelerated photoreceptor aging provides a novel perspective for therapeutic development.
Keywords:
Age-related macular degeneration (AMD)AgingCataractGlaucomaInsulin Diabetic retinopathyLensLongevity pathwaysRetinaRetinal ganglion cellsVision impairments

More Related Videos

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision09:29

A Standardized Obstacle Course for Assessment of Visual Function in Ultra Low Vision and Artificial Vision

Published on: February 11, 2014

13.6K
Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss07:12

Development of a Gaze-Contingent Display Framework Designed for Perceptual and Oculomotor Research with Simulated Central Vision Loss

Published on: April 11, 2025

1.0K

Related Concept Videos

Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
11.1K
The Effect of Aging on Tissues01:19

The Effect of Aging on Tissues

Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
4.1K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption01:22

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
810
Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
1.0K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
323